论文部分内容阅读
目的:探讨抗CD3单抗(CD3McAb)和rIL2共同激活诱生的TAK(Tactivatedkiler)细胞的细胞毒活性本质。方法:采用MTT法分别检测TAK细胞杀伤白血病细胞的活性及其构成。结果:TAK细胞杀伤白血病细胞的活性主要由4部分组成:CD3McAb激活的CD3AK活性约占50%,rIL2诱生的LAK细胞活性约为30%,NK活性约占10%,可溶性抑制性因子的抑制活性约为10%;细胞表型分析TAK细胞主要表达活化T淋巴细胞和NK细胞的表面标志。结论:TAK细胞为异质性细胞群体,其杀伤活性主体为CD3AK活性和LAK活性
Objective: To investigate the cytotoxic activity of TAK (Tactivated killer) cells induced by CD3McAb and rIL2 co-activation. Methods: MTT assay were used to detect TAK cell killing leukemia cell activity and its composition. RESULTS: The activity of T-AK cell-killing leukemia cells was mainly composed of four parts: about 50% of CD3AKs activated by CD3McAb, about 30% of LAK cells induced by rIL-2, about 10% of NK activity, and soluble inhibition The inhibitory activity of the factor is about 10%; Cell phenotype analysis T-AK cells mainly express the surface markers of activated T lymphocytes and NK cells. Conclusion: T AK cells are heterogeneous cell populations, the main killer activity of CD3AK activity and LAK activity